HK$ 8.56
Key Takeaways
Risk factor
High price volatility
Profitability factor
Greatly overvalued vs peers
About
BrainAurora Medical Technology Limited develops medical-grade digital therapy (DTx) products for cognitive impairment. The company offers the evaluation and intervention of cognitive impairments to treat vascular diseases, neurodegenerative diseases, psychological disorders, and child development deficiencies. It develops the Brain Function Information Management Platform software system, an evidence-based, medical-grade DTx product; Cognitive Ability Testing software; the...
Company Valuation
From both historical and forecast perspectives, the stock is considerably overpriced compared to similar stocks.
Target Price
The average target price of 6681.HK is 7.6 and suggests 27% downside potential. Usually, this means a SELL recommendation among investment firms, or a recommendation to d
